Recirculating IL-1R2 Tregs fine-tune intrathymic Treg development under inflammatory conditions.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Mufazalov, Ilgiz A
MetadataShow full item record
AbstractThe vast majority of Foxp3+ regulatory T cells (Tregs) are generated in the thymus, and several factors, such as cytokines and unique thymic antigen-presenting cells, are known to contribute to the development of these thymus-derived Tregs (tTregs). Here, we report the existence of a specific subset of Foxp3+ Tregs within the thymus that is characterized by the expression of IL-1R2, which is a decoy receptor for the inflammatory cytokine IL-1. Detailed flow cytometric analysis of the thymocytes from Foxp3hCD2xRAG1GFP reporter mice revealed that the IL-1R2+ Tregs are mainly RAG1GFP- and CCR6+CCR7-, demonstrating that these Tregs are recirculating cells entering the thymus from the periphery and that they have an activated phenotype. In the spleen, the majority of IL-1R2+ Tregs express neuropilin-1 (Nrp-1) and Helios, suggesting a thymic origin for these Tregs. Interestingly, among all tissues studied, the highest frequency of IL-1R2+ Tregs was observed in the thymus, indicating preferential recruitment of this Treg subset by the thymus. Using fetal thymic organ cultures (FTOCs), we demonstrated that increased concentrations of exogenous IL-1β blocked intrathymic Treg development, resulting in a decreased frequency of CD25+Foxp3+ tTregs and an accumulation of CD25+Foxp3- Treg precursors. Interestingly, the addition of IL-1R2+ Tregs, but not IL-1R2- Tregs, to reaggregated thymic organ cultures (RTOCs) abrogated the IL-1β-mediated blockade, demonstrating that these recirculating IL-1R2+ Tregs can quench IL-1 signaling in the thymus and thereby maintain thymic Treg development even under inflammatory conditions.
CitationCell Mol Immunol. 2020 Jan 27. pii: 10.1038/s41423-019-0352-8. doi: 10.1038/s41423-019-0352-8.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
The following license files are associated with this item:
- Creative Commons
- Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25<sup>high</sup> FOXP3<sup>+</sup> Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive Immunotherapy.
- Authors: Wilkinson DS, Ghosh D, Nickle RA, Moorman CD, Mannie MD
- Issue date: 2017
- Differences in Expression Level of Helios and Neuropilin-1 Do Not Distinguish Thymus-Derived from Extrathymically-Induced CD4+Foxp3+ Regulatory T Cells.
- Authors: Szurek E, Cebula A, Wojciech L, Pietrzak M, Rempala G, Kisielow P, Ignatowicz L
- Issue date: 2015
- Thymus-derived Foxp3<sup>+</sup> regulatory T cells upregulate RORγt expression under inflammatory conditions.
- Authors: Yang J, Zou M, Pezoldt J, Zhou X, Huehn J
- Issue date: 2018 Dec
- Egress of mature murine regulatory T cells from the thymus requires RelA.
- Authors: Fukazawa T, Hiraiwa N, Umemura T, Mise-Omata S, Obata Y, Doi T
- Issue date: 2015 Apr 1
- IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.
- Authors: Cheng G, Yu A, Dee MJ, Malek TR
- Issue date: 2013 Feb 15